Rabbit Recombinant Monoclonal FABP-1 antibody - conjugated to Alexa Fluor® 594.
IgG
Rabbit
Alexa Fluor® 594
Ex: 590nm, Em: 617nm
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Liquid
Monoclonal
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application Target Binding Affinity | Reactivity Expected | Dilution info - | Notes - |
Application Antibody Labelling | Reactivity Expected | Dilution info - | Notes - |
Select an associated product type
Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). As a member of the malate-aspartate shuttle, it has a key role in the intracellular NAD(H) redox balance. Is important for metabolite exchange between mitochondria and cytosol, and for amino acid metabolism. Facilitates cellular uptake of long-chain free fatty acids.
mAspAT, Fatty acid-binding protein, Glutamate oxaloacetate transaminase 2, Kynurenine aminotransferase 4, Kynurenine aminotransferase IV, Kynurenine--oxoglutarate transaminase 4, Kynurenine--oxoglutarate transaminase IV, Plasma membrane-associated fatty acid-binding protein, Transaminase A, FABP-1, FABPpm, GOT2, KYAT4
Rabbit Recombinant Monoclonal FABP-1 antibody - conjugated to Alexa Fluor® 594.
mAspAT, Fatty acid-binding protein, Glutamate oxaloacetate transaminase 2, Kynurenine aminotransferase 4, Kynurenine aminotransferase IV, Kynurenine--oxoglutarate transaminase 4, Kynurenine--oxoglutarate transaminase IV, Plasma membrane-associated fatty acid-binding protein, Transaminase A, FABP-1, FABPpm, GOT2, KYAT4
IgG
Rabbit
Alexa Fluor® 594
Ex: 590nm, Em: 617nm
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 68% PBS, 30% Glycerol (glycerin, glycerine), 1% BSA
Liquid
Monoclonal
EPR12145
Affinity purification Protein A
The mouse and rat recommendation is based on the WB results. We do not guarantee IHC-P for mouse and rat.
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle, Store in the dark
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone. This conjugated antibody is eligible for the Abcam trial program.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Aspartate Aminotransferase (AST) also known as glutamate oxaloacetate transaminase is an enzyme that plays an important role in amino acid metabolism. AST transfers an amino group typically from aspartate to α-ketoglutarate forming oxaloacetate and glutamate. This enzyme approximately weighs 45 kDa. AST is widely expressed in tissues with especially high levels found in the liver heart skeletal muscle and kidneys.
Aspartate aminotransferase participates in the malate-aspartate shuttle which facilitates the transfer of reducing equivalents across the mitochondrial membrane. This shuttle system is important in maintaining the balance of NADH and NAD+ between the cytosol and mitochondria. AST forms part of a protein complex that includes α-ketoglutarate and oxaloacetate which are central to its transaminase activity in cellular metabolism.
Aspartate aminotransferase is significantly involved in the tricarboxylic acid (TCA) cycle and the urea cycle. Within the TCA cycle AST ensures the linkage between carbohydrate and amino acid metabolism by converting aspartate and α-ketoglutarate into oxaloacetate and glutamate. In the urea cycle the enzyme connects to argininosuccinate synthetase and argininosuccinate lyase facilitating the removal of excess nitrogen from the body.
Elevated levels of aspartate aminotransferase are often indicative of liver damage including conditions like hepatitis and cirrhosis. Additionally the enzyme associates with myocardial infarction due to its high activity in cardiac tissue. Liver-related disorders may also involve fatty acid-binding protein 1 (FABP-1) which closely interacts with AST and serves as a marker for liver function and damage.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com